OSU professor to explain the evolution of medicine in Marion talk

A free community lecture on drug design will take place in Marion on July 8.
Ohio State University Professor Ryan Yoder will present 'The Evolution of Drug Design: From Remedies to Rationality' at 5:30 p.m. at Bucci's Italian Scratch Kitchen. The event is part of the Buckeye Talks on Tap lecture series sponsored by The Ohio State University at Marion, according to an annoucement.
Yoder's presentation will explore the history of drug design, detailing how medicines have evolved from ancient remedies to modern therapies. He will discuss the shift from chance discoveries to systematic, science-based approaches in drug development. The lecture also will cover how advancements in technology, research methods, and regulations have influenced the creation and testing of medicines.
Yoder earned his Ph.D. in organic/computation chemistry from The Ohio State University in 2013. He teaches organic chemistry and mentors undergraduate research at the Ohio State Marion campus. His research focuses on drug design for cancer therapies, molecular modeling against toxic organophosphorus nerve agents, and innovative teaching methods in chemical education.
Buckeye Talks on Tap occurs on the second Tuesday of each month at Bucci's Italian Scratch Kitchen, 320 W. Center St., Marion. The series is modeled after the Science Café concept, which promotes engaging discussions between academic experts and the community in relaxed settings.
The lecture series aims to connect Ohio State faculty and community experts with local residents on various topics, including health and wellness, environmental issues, and engineering. The goal is to foster open discussions about subjects relevant to the Marion area.
Attendees are encouraged to enjoy food and drinks during the lecture. Doors will open at 5 p.m. for ordering, with the lecture starting at 5:30 p.m. A question-and-answer session will follow at 6 p.m. Participants will have a chance to win a door prize and enter a monthly drawing for a $500 tuition voucher to The Ohio State University at Marion.
This story was created by Jane Imbody, jimbody@gannett.com, with the assistance of Artificial Intelligence (AI). Journalists were involved in every step of the information gathering, review, editing and publishing process. Learn more at cm.usatoday.com/ethical-conduct/.
This article originally appeared on Marion Star: Free Marion lecture explores how drug design has evolved over time

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Washington Post

27 minutes ago

• Washington Post

Judge blocks the Trump administration's National Science Foundation research funding cuts

BOSTON — A federal judge has blocked President Donald Trump 's administration from making drastic cuts to research funding provided by the National Science Foundation. U.S. District Judge Indira Talwani in Boston struck down on Friday a policy change that could have stripped universities of tens of millions of dollars in research funding. The universities argued the move threatened critical work in artificial intelligence, cybersecurity, semiconductors and other technology fields. Talwani said the change, announced by the NSF in May, was arbitrary and capricious and contrary to law. An email Saturday to the NSF was not immediately returned. At issue are 'indirect' costs, expenses such as building maintenance and computer systems that aren't linked directly to a specific project. Currently, the NSF determines each grant recipient's indirect costs individually and is supposed to cover actual expenses. The Trump administration has dismissed indirect expenses as 'overhead' and capped them for future awards by the NSF to universities at 15 % of the funding for direct research costs. The University of California, one of the plaintiffs, estimated the change would cost it just under $100 million a year. Judges have blocked similar caps that the Trump administration placed on grants by the Energy Department and the National Institutes of Health.

Yahoo

38 minutes ago

• Yahoo

UnitedHealth Group (NYSE:UNH) Announces Debt Financing Totalling US$3 Billion

UnitedHealth Group recently completed a substantial debt financing deal, raising $3 billion through the issuance of various Notes. This move comes amid a period of legal settlements, such as the $69 million ERISA case, and operational restructuring, including exploring bids for its Latin American operations. Despite these significant developments, the company's stock price remained relatively flat over the last month, reflecting broader market trends which also showed minimal movement. The dividend increase and shareholder discussions on executive compensation may have subtly influenced sentiment, but overall, these events seemed to align with the market's flat performance. UnitedHealth Group has 1 possible red flag we think you should know about. Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit. UnitedHealth Group's recent $3 billion debt financing and restructuring efforts, such as evaluating bids for its Latin American operations, are significant developments. While the near-term stock price remained relatively stable amid these changes, over the past five years, the company's total shareholder return, including dividends, was 13.61%. This reflects a steady growth trajectory, although in the last year, UnitedHealth underperformed the US Healthcare industry. The current share price sees a slight discount from the analyst consensus price target of $547.65, which is 28% higher than the present value. Despite recent legal settlements and compensation discussions, the company's aggressive push towards digital tools and Medicare adjustments might bolster future earnings and revenue. UnitedHealth's projected earnings per share and revenue growth is positioned slightly behind broader market expectations over the next few years, yet planned improvements in operational efficiencies could bridge this gap over time. Learn about UnitedHealth Group's future growth trajectory here. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:UNH. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Associated Press

44 minutes ago

• Associated Press

Judge blocks the Trump administration's National Science Foundation research funding cuts

BOSTON (AP) — A federal judge has blocked President Donald Trump 's administration from making drastic cuts to research funding provided by the National Science Foundation. U.S. District Judge Indira Talwani in Boston struck down on Friday a policy change that could have stripped universities of tens of millions of dollars in research funding. The universities argued the move threatened critical work in artificial intelligence, cybersecurity, semiconductors and other technology fields. Talwani said the change, announced by the NSF in May, was arbitrary and capricious and contrary to law. An email Saturday to the NSF was not immediately returned. At issue are 'indirect' costs, expenses such as building maintenance and computer systems that aren't linked directly to a specific project. Currently, the NSF determines each grant recipient's indirect costs individually and is supposed to cover actual expenses. The Trump administration has dismissed indirect expenses as 'overhead' and capped them for future awards by the NSF to universities at 15 % of the funding for direct research costs. The University of California, one of the plaintiffs, estimated the change would cost it just under $100 million a year. Judges have blocked similar caps that the Trump administration placed on grants by the Energy Department and the National Institutes of Health.